Partnership brings the world's first integrated on-site saliva-based drugs of abuse diagnostic system from the UK to the USA
Dominion Life Sciences announces a partnership with Cozart Bioscience, a UK-based medical diagnostics company, to become the exclusive US distributor of Cozart RapiScan, the world's first integrated on-site oral fluid (saliva) based drugs of abuse diagnostic system.
"When you think of new, when you think of innovative, you should be thinking Dominion" said Frank Fornari, Dominion CEO.
"RapiScan has a wide range of applicability and includes a new, accurate ease of testing (simultaneous results within minutes) for law enforcement, work place, government, medical emergencies, wellness/health screening and more".
The hand held, FDA approved RapiScan detects a broad drugs of abuse menu, including amphetamine, benzodiazepines, cannabinoids, cocaine, opiates, methadone, methamphetamine, phencyclidine, and buprenorphine.
Several new panels are currently in development.
